flumazenil has been researched along with oxazepam in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (26.92) | 18.7374 |
| 1990's | 8 (30.77) | 18.2507 |
| 2000's | 6 (23.08) | 29.6817 |
| 2010's | 5 (19.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hönack, D; Löscher, W | 1 |
| Martin, WR; Pruitt, TA; Sloan, JW; Wala, EP | 1 |
| Roth, SH; Sewell, RD; Tan, KS | 3 |
| de la Garza, R; Evans, S; Johanson, CE | 1 |
| Martin, WR; McNicholas, LF; Sloan, JW; Wala, E | 1 |
| Galletly, DC; Maling, T; Short, TG | 1 |
| File, SE; Wilks, LJ | 1 |
| Jenck, F; Martin, JR; Moreau, JL | 1 |
| Marinelli, FC; Pals, JK; Thibault, GE; Weinberg, AD | 1 |
| Martin, WR; Sloan, JW; Wala, EP | 1 |
| Sloan, JW; Wala, EP | 1 |
| Jing, X; Sloan, JW; Wala, EP | 1 |
| Blanc, F; Butterworth, RF; Fabbro-Peray, P; Lavoie, J; Layrargues, GP; Mousseau, DD; Perney, P | 1 |
| Brewer, C; Gerra, G; Giusti, F; Moi, G; Zaimovic, A | 1 |
| Lamas, E; Pellón, R; Rodríguez, C; Ruíz, A | 1 |
| Goeders, NE; Guerin, GF; Spence, AL | 1 |
1 review(s) available for flumazenil and oxazepam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for flumazenil and oxazepam
| Article | Year |
|---|---|
Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
Topics: Adult; Anti-Anxiety Agents; Antidotes; Benzodiazepines; Blood Pressure; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Flumazenil; Heart Rate; Humans; Injections, Intravenous; Male; MMPI; Oxazepam; Personality Disorders; Substance Withdrawal Syndrome; Wechsler Scales | 2002 |
24 other study(ies) available for flumazenil and oxazepam
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant beta-carboline abecarnil.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Behavior, Animal; Carbolines; Diazepam; Dogs; Female; Flumazenil; GABA-A Receptor Antagonists; Oxazepam; Substance Withdrawal Syndrome | 1992 |
The effects of flumazenil-precipitated abstinence on the pharmacokinetics of chronic oxazepam in dogs.
Topics: Administration, Oral; Animals; Biological Availability; Dogs; Drug Interactions; Female; Flumazenil; Injections, Intravenous; Oxazepam; Substance-Related Disorders | 1990 |
Benzodiazepines produce contrasting effects on the active membrane properties of an invertebrate neuron.
Topics: Action Potentials; Animals; Anti-Anxiety Agents; Astacoidea; Benzodiazepinones; Electric Conductivity; Flumazenil; Flurazepam; In Vitro Techniques; Membrane Potentials; Neurons, Afferent; Oxazepam | 1985 |
Discriminative stimulus properties of oxazepam in the pigeon.
Topics: Animals; Anti-Anxiety Agents; Columbidae; Discrimination Learning; Flumazenil; Oxazepam; Pentobarbital; Pyridazines | 1987 |
Precipitation of abstinence in nordiazepam- and diazepam-dependent dogs.
Topics: Analysis of Variance; Animals; Diazepam; Dogs; Flumazenil; Nordazepam; Oxazepam; Pyrazoles; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders | 1988 |
Ventricular arrhythmia precipitated by flumazenil.
Topics: Adult; Chloral Hydrate; Electrocardiography; Female; Flumazenil; Heart Ventricles; Humans; Oxazepam; Tachycardia | 1988 |
Does the behavioural activation detected after a single dose of a benzodiazepine reflect a withdrawal response?
Topics: Animals; Behavior, Animal; Benzodiazepines; Flumazenil; Lorazepam; Male; Mice; Motor Activity; Oxazepam | 1988 |
Synaptic and non-synaptic actions of benzodiazepines on the crayfish sensory neuron.
Topics: Action Potentials; Animals; Anti-Anxiety Agents; Astacoidea; Benzodiazepinones; Flumazenil; Flurazepam; In Vitro Techniques; Mechanoreceptors; Membrane Potentials; Neurons, Afferent; Oxazepam; Receptors, Neurotransmitter | 1984 |
Evidence for excitatory and depressant non-receptor-mediated membrane effects of benzodiazepines in the crayfish.
Topics: Animals; Astacoidea; Benzodiazepines; Benzodiazepinones; Cell Membrane; Electrophysiology; Flumazenil; Flurazepam; Neurons, Afferent; Oxazepam; Physical Stimulation | 1984 |
Precipitated withdrawal in squirrel monkeys after repeated daily oral administration of alprazolam, diazepam, flunitrazepam or oxazepam.
Topics: Administration, Oral; Alprazolam; Animals; Behavior, Animal; Diazepam; Dose-Response Relationship, Drug; Drug Tolerance; Female; Flumazenil; Flunitrazepam; Male; Muscle Relaxation; Oxazepam; Saimiri; Sleep; Substance Withdrawal Syndrome; Substance-Related Disorders; Tremor | 1995 |
Oxazepam overdose associated with ethanol ingestion: treatment with a benzodiazepine antagonist.
Topics: Alcohol Drinking; Benzodiazepines; Drug Interactions; Drug Overdose; Flumazenil; Humans; Male; Middle Aged; Oxazepam | 1994 |
Pharmacokinetics of nordiazepam in physical dependence and precipitated abstinence in dogs.
Topics: Administration, Oral; Animals; Blood Proteins; Diazepam; Dogs; Female; Flumazenil; Hydrolysis; Injections, Intravenous; Nordazepam; Oxazepam; Protein Binding; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Flumazenil, diazepam, nordiazepam and oxazepam interactions on plasma protein binding.
Topics: Animals; Anti-Anxiety Agents; Biotransformation; Blood Proteins; Diazepam; Dogs; Drug Interactions; Flumazenil; In Vitro Techniques; Nordazepam; Oxazepam; Protein Binding | 1995 |
The effect of chronic benzodiazepines exposure on body weight in rats.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Body Weight; Diazepam; Dose-Response Relationship, Drug; Female; Flumazenil; Flunitrazepam; GABA Modulators; Male; Nordazepam; Oxazepam; Rats; Rats, Sprague-Dawley; Sex Factors; Time Factors; Weight Gain | 1998 |
Plasma and CSF benzodiazepine receptor ligand concentrations in cirrhotic patients with hepatic encephalopathy: relationship to severity of encephalopathy and to pharmaceutical benzodiazepine intake.
Topics: Animals; Benzodiazepines; Binding, Competitive; Cell Fractionation; Cerebellum; Chronic Disease; Clonazepam; Diazepam; Flumazenil; GABA Modulators; Hepatic Encephalopathy; Humans; Isoquinolines; Liver Cirrhosis; Oxazepam; Radioligand Assay; Rats; Receptors, GABA-A; Tritium | 1998 |
Pharmacological analysis of the effects of benzodiazepines on punished schedule-induced polydipsia in rats.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Chlordiazepoxide; Diazepam; Dose-Response Relationship, Drug; Drinking; Electroshock; Fear; Flumazenil; Food Deprivation; GABA Modulators; Imidazoles; Male; Oxazepam; Punishment; Pyrimidines; Rats; Rats, Wistar; Receptors, GABA-A; Reinforcement Schedule | 2007 |
The differential effects of alprazolam and oxazepam on methamphetamine self-administration in rats.
Topics: Alprazolam; Amphetamine-Related Disorders; Animals; Dose-Response Relationship, Drug; Flumazenil; Isoquinolines; Male; Methamphetamine; Oxazepam; Premedication; Rats; Rats, Wistar; Receptors, GABA-A; Self Administration | 2016 |